Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

Clonal Hematopoiesis and Genetic Mutations in Individual Patients with Acquired Bone Marrow Failure Diseases

Baixin Ye, Xinhua Du, Li Yan, Qingping Gao, Chunrui Li, MD PhD, Jianfeng Zhou, Xin Yi, Fankai Meng

Blood (2019) 134 (Supplement_1): 937.

https://doi.org/10.1182/blood-2019-125357

Published: 2019

Journal Articles

Hierarchical Differences in Defensin Gene Expression in Plasmacytoid Dendritic Cells and Progenitor Cells from Five Different Hematopoietic Stem Cell Transplant Graft Types

Cynthia R. Giver, PhD, Ernestine Anna Mahar, B.S., Sakura Hosoba, MD, Jeanne Kowalski, PhD, Sandra Seby, MSc, Xinyan A. Zhang, PhD MPH, Steven M. Devine, MD, Edmund K. Waller, MD

Blood (2017) 130 (Supplement 1): 1924.

https://doi.org/10.1182/blood.V130.Suppl_1.1924.1924

Published: 2017

Journal Articles

CD68 + CD163 + M2-like Macrophages and Myeloid-Derived Suppressor Cells in Primary Immune Thrombocytopenia

Yunfeng Cheng, MD PhD, Xia Shao, Boting Wu, Yanxia Zhan, Lili Ji, Luya Cheng, Chanjuan Liu, Feng Li

Blood (2017) 130 (Supplement 1): 4844.

https://doi.org/10.1182/blood.V130.Suppl_1.4844.4844

Published: 2017

Journal Articles

Analysis of Interactions between CD14+ Monocytes, Mesenchymal Stem Cells and HeLa Cells in Double Co-Cultures In Vitro

Kristina Kitaeva, Tikhon Prudnikov, Marina Gomzikova, PhD, Leisan Tazetdinova, Albert Rizvanov, DSc, PhD, Valeriya Soloveva, PhD

Blood (2017) 130 (Supplement 1): 4809.

https://doi.org/10.1182/blood.V130.Suppl_1.4809.4809

Published: 2017

Journal Articles

ENESTPath: A Phase 3 Study to Assess the Effect of Nilotinib Treatment Duration on Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated with Imatinib: 24-Month Analysis of the First 300 Patients in the Induction/Consolidation Phase

Delphine Rea, MD PhD, Gianantonio Rosti, MD, Nicholas CP Cross, MA, PhD, Andrzej Hellmann, MD PhD, Dietger Niederwieser, MD, Ester Pungolino, MD, Franca Falzetti, MD, Patrizia Pregno, MD, Ester Maria Orlandi, MD, Antonio Almeida, MD PhD, Arpad Illes, MD PhD, Miguel Sagues, MD, Jens Haenig, PhD, Sharon Supekar, MSc, Seema Shah, MSc, Giuseppe Saglio, MD, Juan Luis Steegmann, MD, Michele Baccarani, MD

Blood (2016) 128 (22): 3094.

https://doi.org/10.1182/blood.V128.22.3094.3094

Published: 2016

Journal Articles

Clonal Selection in Acute Myeloid Leukemia Following Intensive Induction Correlates with Differences in Differentiation Capacity of Leukemic Sub-Clones

Michal Hayun, PhD, Maria Zaatra, MSc, Dvora Sahar, PhD, Dina Rosenberg, PhD, Igal Louria-Hayon, PhD, Yishai Ofran, MD

Blood (2016) 128 (22): 1697.

https://doi.org/10.1182/blood.V128.22.1697.1697

Published: 2016

Journal Articles

Development of Second Primary Malignancies in Multiple Myeloma Patients Treated with Lenalidomide: An Alberta Perspective

Katherine Fung, BSP, ACPR, Peter Duggan, MD FRCPC, Carole Chambers, BScPharm, MBA, FCSHP, FISOPP, Patrick Shui-Lun Yau, BPharm, Deonne Dersch-Mills, BScPharm, ACPR, PharmD, Frances Cusano, BScPharm, ACPR, Nizar J Bahlis, Sunita Ghosh, PhD, P.Stat.

Blood (2016) 128 (22): 4528.

https://doi.org/10.1182/blood.V128.22.4528.4528

Published: 2016

Journal Articles

Genetic Analysis of Distinct Phenotypic Subsets within MM1.S Multiple Myeloma Cell Line Reveals the Pre-Existence of MM.1R-like Glucocorticoid Resistance and a Sub-Clone with an Activating PI3-Kinase Delta Mutation That Is Preferentially Sensitive to the Selective PI3-Kinase Inhibitor, Idelalisib

James W Murray, MBBCh, Christopher Fegan, Chris Pepper, PhD

Blood (2016) 128 (22): 4449.

https://doi.org/10.1182/blood.V128.22.4449.4449

Published: 2016

Journal Articles

Targeting Cancer Stem Cell Survival in Plasma Cell Leukemia with a Pan-BCL2 Inhibitor

Elisa Lazzari, MA, Leslie A Crews, PhD, Christina Wu, PhD, Heather Leu, BS, Raffaella Chiaramonte, PhD, Mark D. Minden, MD PhD, Caitlin L. Costello, MD, Catriona Jamieson, MD PhD

Blood (2015) 126 (23): 5351.

https://doi.org/10.1182/blood.V126.23.5351.5351

Published: 2015

Journal Articles

Cytokine Profiling of ABC-Subtype and GCB-Subtype Diffuse Large B Cell Lymphoma: Systemic Nfkb Activation and Impact on Myeloid-Derived Suppressor Cells Distribution

David Foureau, PhD, Lawrence J Druhan, PhD, Nury M Steuerwald, PhD, Sarah A Baxter, PhD, Omotayo O. Fasan, MBBS, MRCP, Belinda R Avalos, MD, Nilanjan Ghosh, MD PhD

Blood (2015) 126 (23): 2666.

https://doi.org/10.1182/blood.V126.23.2666.2666

Published: 2015

Journal Articles

Highly Restricted Usage of Immunoglobulin Light Chain IGKV3-20 with Stereotyped Sequence in Primary Cold-Agglutinin Disease (CAD)

Agnieszka Malecka, Gunhild Trøen, PhD, Anne Tierens, MD PhD, Ingunn Østlie, Ulla Randen, MD PhD, Sigbjorn Berentsen, MDPhD, Geir Tjønnfjord, MD PhD, Jan M.A. Delabie, MD PhD

Blood (2015) 126 (23): 4137.

https://doi.org/10.1182/blood.V126.23.4137.4137

Published: 2015

Journal Articles

Single Cell Analysis of IG Genes in CLL: Cases with Multiple IGH Rearrangements Are Constituted of Several Independent Clones Even When Indistinguishable By Flow Cytometry

Kamila Brazdilova, MSc., Karla Plevova, PhD, Hana Skuhrova Francova, MSc, Helena Kockova, MSc, Magdalena Chmelikova, MSc, Marek Borsky, MSc., Katerina Burckova, MSc, Barbara Kantorova, MSc, Boris Tichy, PhD, Hana Skabrahova, Yvona Brychtova, PhD, MD, Jiri Mayer, Prof, MD PhD, Michael Doubek, MD PhD, Sarka Pospisilova, Prof.

Blood (2015) 126 (23): 4139.

https://doi.org/10.1182/blood.V126.23.4139.4139

Published: 2015

Journal Articles

A Germline Mutation in ERBB3 Predisposes to Inherited Erythroid Myelodysplasia/Erythroleukemia

Evan M. Braunstein, MD PhD, Ruijuan Li, Nara Sobreira, MD, Christopher Gocke, MD, Robert A. Brodsky, MD, David Valle, MD, Linzhao Cheng, PhD

Blood (2015) 126 (23): 4105.

https://doi.org/10.1182/blood.V126.23.4105.4105

Published: 2015

Journal Articles

Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) As Salvage Therapy for Adult Patients with Refractory/Relapse (R/R) Acute Lymphoblastic Leukemia (ALL)

Elias Jabbour, MD, Susan O'Brien, Deborah A. Thomas, MD, Koji Sasaki, Guillermo Garcia-Manero, MD, Tapan Kadia, MD, Nitin Jain, MD, Sergernne York, RN, Rebecca Garris, BSc, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD

Blood (2014) 124 (21): 964.

https://doi.org/10.1182/blood.V124.21.964.964

Published: 2014

Journal Articles

Presence of JAK2V617F Mutation in Endothelial Cells from Budd-Chiari Syndrome Patients Is Not Correlated with Ph-Negative Myeloproliferative Neoplasm

Ricardo Helman, MD, Welbert Oliveira Pereira, PhD, Paulo Vidal Campregher, MD, Luciana Cavalheiro Marti, PhD, Nelson Hamerschlak, MD PhD, Isabel Bello, Sandra Saemi Nakashima, Carlos S Chiattone, MD PhD, Fabio P S Santos, MD

Blood (2014) 124 (21): 4998.

https://doi.org/10.1182/blood.V124.21.4998.4998

Published: 2014

Journal Articles

Pharmacokinetic (PK) Comparison of Two Fibrinogen Concentrates for the Treatment of Congenital Fibrinogen Deficiency

Bruce A. Schwartz, PhD, Savita Rangarajan, MBBS, FRCP, FRCPath, Flora Peyvandi, Mehran Karimi, MD, Sigurd Knaub, PhD

Blood (2014) 124 (21): 2817.

https://doi.org/10.1182/blood.V124.21.2817.2817

Published: 2014

Journal Articles

Autophagy Collaborates with Ubiquitination to Down-Regulate Oncoprotein E2A/Pbx1 in B Cell Acute Lymphoblastic Leukemia

Suping Zhang, MD PhD, Lin Song, BS, Na Yuan, BS, Weiwei Lin, MS, Yan Cao, BS, Fei Xu, MS, Yixuan Fang, BS, Zheng Wang, BS, Xin Li, BS, Zhijian Wang, MS, Jinyang Cai, MS, Wenli Zhao, MD PhD, Shaoyan Hu, MD PhD, Suning Chen, MD PhD, Xinliang Mao, MD PhD, Jianrong Wang, PhD

Blood (2014) 124 (21): 5276.

https://doi.org/10.1182/blood.V124.21.5276.5276

Published: 2014

Journal Articles

Lineage-Specific Distribution of CALR EXON 9, JAK2V617F, MPLW515L/K, NPM1 and FLT3 Mutations in Myeloid Disorders

Bettina Burnworth, PhD, Richard Bennington, Wayne Fritschle, MT, Phung Nguyen, Stephanie Verkamp, Bennington Angela, MB (ASCP), Collette Wentzel, Lisa Broderson, PhD, Michael R. Loken, PhD, Denise A. Wells, MD, Barbara Katharina Zehentner, PhD

Blood (2014) 124 (21): 5573.

https://doi.org/10.1182/blood.V124.21.5573.5573

Published: 2014

Journal Articles

CD137 Expression Identifies Leukemia Specific CTL After In Vitro Priming Of Cord Blood T Cells

Jeyaraj Antony, PhD, Xiaohua Chen, PhD, Paul Szabolcs, MD

Blood (2013) 122 (21): 3266.

https://doi.org/10.1182/blood.V122.21.3266.3266

Published: 2013

Journal Articles

Epigenetic Status Of CEBPA Promoter and Expression Of CEBPα Correlates With Molecular Genetic Subtype and CD2 Aberrant Expression In B Cell Precursor ALL

Lucie Slamova, Julia Starkova, Karel Fiser, Eva Fronkova, Leona Rezkova Reznickova, Marketa Kubricanova Zaliova, Kamila Polgarova, Jan Stary, Jan Trka, Ondrej Hrusak, Ester Mejstrikova

Blood (2013) 122 (21): 2573.

https://doi.org/10.1182/blood.V122.21.2573.2573

Published: 2013

NARROW

Clonal Hematopoiesis and Genetic Mutations in Individual Patients with Acquired Bone Marrow Failure Diseases

Hierarchical Differences in Defensin Gene Expression in Plasmacytoid Dendritic Cells and Progenitor Cells from Five Different Hematopoietic Stem Cell Transplant Graft Types

CD68 + CD163 + M2-like Macrophages and Myeloid-Derived Suppressor Cells in Primary Immune Thrombocytopenia

Analysis of Interactions between CD14+ Monocytes, Mesenchymal Stem Cells and HeLa Cells in Double Co-Cultures In Vitro

ENESTPath: A Phase 3 Study to Assess the Effect of Nilotinib Treatment Duration on Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated with Imatinib: 24-Month Analysis of the First 300 Patients in the Induction/Consolidation Phase

Clonal Selection in Acute Myeloid Leukemia Following Intensive Induction Correlates with Differences in Differentiation Capacity of Leukemic Sub-Clones

Development of Second Primary Malignancies in Multiple Myeloma Patients Treated with Lenalidomide: An Alberta Perspective

Genetic Analysis of Distinct Phenotypic Subsets within MM1.S Multiple Myeloma Cell Line Reveals the Pre-Existence of MM.1R-like Glucocorticoid Resistance and a Sub-Clone with an Activating PI3-Kinase Delta Mutation That Is Preferentially Sensitive to the Selective PI3-Kinase Inhibitor, Idelalisib

Targeting Cancer Stem Cell Survival in Plasma Cell Leukemia with a Pan-BCL2 Inhibitor

Cytokine Profiling of ABC-Subtype and GCB-Subtype Diffuse Large B Cell Lymphoma: Systemic Nfkb Activation and Impact on Myeloid-Derived Suppressor Cells Distribution

Highly Restricted Usage of Immunoglobulin Light Chain IGKV3-20 with Stereotyped Sequence in Primary Cold-Agglutinin Disease (CAD)

Single Cell Analysis of IG Genes in CLL: Cases with Multiple IGH Rearrangements Are Constituted of Several Independent Clones Even When Indistinguishable By Flow Cytometry

A Germline Mutation in ERBB3 Predisposes to Inherited Erythroid Myelodysplasia/Erythroleukemia

Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) As Salvage Therapy for Adult Patients with Refractory/Relapse (R/R) Acute Lymphoblastic Leukemia (ALL)

Presence of JAK2V617F Mutation in Endothelial Cells from Budd-Chiari Syndrome Patients Is Not Correlated with Ph-Negative Myeloproliferative Neoplasm

Pharmacokinetic (PK) Comparison of Two Fibrinogen Concentrates for the Treatment of Congenital Fibrinogen Deficiency

Autophagy Collaborates with Ubiquitination to Down-Regulate Oncoprotein E2A/Pbx1 in B Cell Acute Lymphoblastic Leukemia

Lineage-Specific Distribution of CALR EXON 9, JAK2V617F, MPLW515L/K, NPM1 and FLT3 Mutations in Myeloid Disorders

CD137 Expression Identifies Leukemia Specific CTL After In Vitro Priming Of Cord Blood T Cells

Epigenetic Status Of CEBPA Promoter and Expression Of CEBPα Correlates With Molecular Genetic Subtype and CD2 Aberrant Expression In B Cell Precursor ALL

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only